Advertisement
Annals
Established in 1927 by the American College of Physicians
:
Advanced search

Cover Image   
box In this Issue
  arrow Articles
  arrow Brief Communications
  arrow Academia and Clinic
  arrow Clinical Guidelines
  arrow Editorials
  arrow On Being a Doctor
  arrow Letters
  arrow Medical Writings: Book Notes
  arrow Ad Libitum
  arrow Ancillary Content
  arrow Summaries for Patients
  arrow PDF of Contents
box Services
  arrow Subscribe
  arrow One-time access
  arrow Activate online subscription
  arrow Access Personal Archive
 
box In this Issue
  arrow Articles
  arrow Brief Communications
  arrow Academia and Clinic
  arrow Clinical Guidelines
  arrow Editorials
  arrow On Being a Doctor
  arrow Letters
  arrow Medical Writings: Book Notes
  arrow Ad Libitum
  arrow Ancillary Content
  arrow Summaries for Patients
  arrow PDF of Contents
box Services
  arrow Subscribe
  arrow One-time access
  arrow Activate online subscription
  arrow Access Personal Archive
 

TABLE OF CONTENTS

16 July 2002 Volume 137 Issue 2
< Previous Issue  |  Next Issue >
Clear

Articles Back

James E. Peacock, Jr., Deirdre A. Herrington, James C. Wade, Hillard M. Lazarus, Michael D. Reed, Jane W. Sinclair, Daniel C. Haverstock, Steven F. Kowalsky, David D. Hurd, Deborah A. Cushing, Colleen P. Harman, and Gerald R. Donowitz

Empirical therapy with an aminoglycoside and a ß-lactam remains common for febrile neutropenic patients. Concerns about aminoglycoside-induced ototoxicity and nephrotoxicity have led to studies of alternate regimens. In this study, ciprofloxacin–piperacillin was as safe and effective as tobramycin–piperacillin for empirical therapy of neutropenic fever.

Abstract | Full Text | PDF | Summary for Patients

Harry P. Selker, Joni R. Beshansky, John L. Griffith for the TPI Trial Investigators*

Although its effect was minimal on patients with high baseline reperfusion rates, the electrocardiograph-based Thrombolytic Predictive Instrument increased use and timeliness of reperfusion in often-missed groups and when involved physicians were off site.

Abstract | Full Text | PDF | Summary for Patients

Michael Pignone, Somnath Saha, Tom Hoerger, and Jeanne Mandelblatt

Screening for colorectal cancer appears cost-effective compared with no screening, but a single optimal strategy cannot be determined from the currently available data. Additional data and additional analyses are necessary.

Abstract | Full Text | PDF | Summary for Patients


Brief Communications Back

Philip C. Johnson, L. Joseph Wheat, Gretchen A. Cloud, Mitchell Goldman, Dan Lancaster, David M. Bamberger, William G. Powderly, Richard Hafner, Carol A. Kauffman, William E. Dismukes for the U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group*

In patients with moderate to severe histoplasmosis associated with AIDS, the preferred treatment has been the deoxycholate formulation of amphotericin B. However, serious side effects are associated with this drug. This study found that liposomal amphotericin B was less toxic than amphotericin B and was associated with improved survival.

Abstract | Full Text | PDF | Summary for Patients


Academia and Clinic Back

David W. Bates

This article analyzes the case of a patient with iatrogenic hypoglycemia due to administration of the wrong medication. The institution's "root-cause analysis" of the factors contributing to this particular adverse event and the institution's response are discussed, and the literature on preventing medication errors is reviewed.

Abstract | Full Text | PDF

Joanne Lynn, Kevin Nolan, Andrea Kabcenell, David Weissman, Casey Milne, Donald M. Berwick for the End-of-Life Care Consensus Panel*

Most people in developed countries will live with a serious, eventually fatal, chronic condition for months or years before dying, yet the delivery of health care services has only recently begun adapting to this reality. Lynn and colleagues discuss a composite case study in a nursing home setting, which builds on experience with multisite collaborative efforts and introduces quality improvement methods in the context of end-of-life care.

Abstract | Full Text | PDF


Clinical Guidelines Back

U.S. Preventive Services Task Force*

The U.S. Preventive Services Task Force strongly recommends that clinicians routinely provide colorectal cancer screening for all adults 50 years of age or older.

Abstract | Full Text | PDF

Michael Pignone, Melissa Rich, Steven M. Teutsch, Alfred O. Berg, and Kathleen N. Lohr

This systematic review supports the U.S. Preventive Services Task Force's position on screening for colorectal cancer.

Abstract | Full Text | PDF


Editorials Back

Lindsey R. Baden and Robert H. Rubin

The management of the patient with cancer who has chemotherapy-induced neutropenia and fever has changed markedly over the past four decades. Empirical antimicrobial therapy is now the standard of care for any patient with cancer and neutropenia who has unexplained fever, rigors, or subtler signs of sepsis. The study by Peacock and colleagues in this issue adds significantly to our understanding of the effect of this approach in patients with cancer.

Full Text | PDF

Sanjay Saint, Benjamin A. Lipsky, and Susan Dorr Goold

More than four decades ago, Dr. Paul Beeson persuasively argued against routine use of indwelling urinary catheters in hospitalized patients, making the "case against the catheter." This advice remains relevant today.

Full Text | PDF


On Being a Doctor Back

Neil Nakadate

My father's precise, thorough ways as a fly fisherman told you what to expect of his ways in the practice of anesthesiology.

Full Text | PDF


Letters Back

Physicians and Joint Negotiations

Blue Light and Milk

Fruit and Vegetable Intake and Coronary Heart Disease

    Alexandra Alves-Rodrigues and Boban Thomas

    Full Text | PDF

    Peter Lindenauer, Darius A. Rastegar, and Dorothea von Goeler

    Full Text | PDF

    Kaumudi J. Joshipura, Frank B. Hu, and Walter C. Willett—RESPONSE

    Full Text | PDF

Questioning the Treatment of Venous Thromboembolism

Rapid-Onset Type 1 Diabetes Mellitus without Pancreatic Exocrine Dysfunction

Hepatotoxicity after Prophylaxis with a Nevirapine-Containing Antiretroviral Regimen

    Stuart Johnson, Juliana Chan, and Charles L. Bennett

    Full Text | PDF

Correction: The Reliability of Medical Record Review for Estimating Adverse Event Rates



Medical Writings: Book Notes Back

Catherine V. Caldicott

Full Text | PDF

Rita Charon

Full Text | PDF


Ad Libitum Back

Loreen Herwaldt

Full Text | PDF


Ancillary Content Back

Full Text | PDF

Full Text | PDF


Summaries for Patients Back

Full Text | PDF

Full Text | PDF

Full Text | PDF

Full Text | PDF



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2008 by the American College of Physicians.